Karen Prange, Director at AtriCure, Inc. (ATRC), sold 3,564 shares at $38.80 ($138K) on 2026-08-05, disclosed to the SEC on 2026-08-07.
Open-market sale of $138k ATRC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VRAY | SELL | 2023-07-21 | $9K | — | Filing → |
| ATRC | SELL | 2023-06-12 | $34K | — | Filing → |
| VRAY | BUY | 2022-05-12 | $100K | — | Filing → |